A comprehensive analysis of a urine sample designed to detect the presence of twelve distinct classes of drugs or their metabolites. This type of test provides a broader scope compared to simpler screenings, identifying a wider range of substances that may indicate drug use. For example, it can simultaneously screen for substances like amphetamines, barbiturates, benzodiazepines, cocaine, marijuana (THC), opioids, phencyclidine (PCP), methadone, propoxyphene, and others depending on the specific panel configuration.
These analyses are utilized in various settings due to their ability to provide a relatively quick and cost-effective method for identifying potential substance abuse. Its adoption has grown over time as the need for thorough and efficient drug detection increased across industries, including employment, healthcare, and legal contexts. Benefits include improved workplace safety, monitoring of prescription medication adherence, and aiding in legal or probationary requirements. The results, when combined with other factors, can provide vital information.
